UGT1A7 and UGT1A9 polymorphisms predict response and toxicity in colorectal cancer patients treated with capecitabine/irinotecan.

Source:http://linkedlifedata.com/resource/pubmed/id/15709193

Clin. Cancer Res. 2005 Feb 1 11 3 1226-36

Download in:

View as

Triples

General Info

PMID
15709193